Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRSN

NeuroSense Therapeutics Ltd

Apr 30 • 04:00PM ET

0.8210

+0.0179 2.23 %

Healthcare • Biotechnology • Israel • Nano • NASD

Peers: BIIB LLY REGN VRTX GILD AMGN ONC ALNY MRNA NBIX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	32.30%	Shs Outstand	35.35M	Perf Week	14.84%
Market Cap	29.02M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	0.00%	Shs Float	23.93M	Perf Month	8.74%
Enterprise Value	-	PEG	-	EPS next Q	-0.08	Inst Own	0.98%	Short Float	2.73%	Perf Quarter	-13.57%
Income	-	P/S	-	EPS this Y	26.06%	Inst Trans	5.48%	Short Ratio	4.00	Perf Half Y	-25.36%
Sales	-	P/B	-	EPS next Y	-56.53%	ROA	-	Short Interest	0.65M	Perf YTD	6.76%
Book/sh	-	P/C	-	EPS next 5Y	15.62%	ROE	-	52W High	2.60 -68.42%	Perf Year	-16.22%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	25.89% 21.42%	ROIC	-	52W Low	0.63 30.32%	Perf 3Y	-59.36%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.34% 7.22%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	31.09%	Oper. Margin	-	ATR (14)	0.06	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	61.04	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	59.59%	SMA20	10.80%	Beta	1.58	Target Price	8.38
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	3.84%	Rel Volume	1.44	Prev Close	0.80
Employees	16	LT Debt/Eq	-	Earnings	Mar 31 BMO	SMA200	-22.17%	Avg Volume	163.53K	Price	0.82
IPO	Dec 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-160.03% -	Trades		Volume	245,490	Change	2.23%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)